Clinical Trial

Extended-field Proton Therapy for Cervical Cancer

Name: Extended-field Proton Therapy for Cervical Cancer — clinical trial record (NCT07298642)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

Severe lymphopenia is a common complication of extended-field radiotherapy in cervical cancer, significantly impacting immune function and clinical outcomes. This study aims to evaluate whether proton therapy, with its superior dose distribution, can reduce lymphopenia and improve survival and toxicity profiles compared to photon therapy.

Trial Details

NCT Number	NCT07298642
Lead Sponsor	National Taiwan University Hospital
Conditions	Cervical Cancer
Enrollment	44 participants
Start Date	2025-09-30
Primary Completion	2030-05 (estimated)
Study Completion	2030-05 (estimated)
Updated on ClinicalTrials.gov	2025-12-23